發送短信 : Randomized phase II study of two intercalated combinations of eribulin mesylate and erlotinib in patients with reviously treated advanced non-small-cell lung cancer

  ____     __   __   ______      ___     _    _   
 |  _ \\   \ \\/ // |      \\   / _ \\  | || | || 
 | |_| ||   \ ` //  |  --  //  | / \ || | || | || 
 | .  //     | ||   |  --  \\  | \_/ || | \\_/ || 
 |_|\_\\     |_||   |______//   \___//   \____//  
 `-` --`     `-`'   `------`    `---`     `---`